<DOC>
	<DOCNO>NCT00746252</DOCNO>
	<brief_summary>The purpose study learn weight gain related side effect child treat antipsychotic medicine mood disorder .</brief_summary>
	<brief_title>Side Effect Study Antipsychotic Medicines Treat Childhood Bipolar Disorder</brief_title>
	<detailed_description>This protocol six month , randomize , open label trial risperidone versus aripiprazole antipsychotic naive youth ( 7 - 12 year old ) identify clinical treatment provider need antipsychotic treatment bipolar disorder . This study propose monitor change metabolic parameter ( body mass index percentile , % body fat , insulin resistance , lipid level ) course six month treatment aripiprazole risperidone youth bipolar spectrum disorder . We also assess possible mechanism second generation antipsychotic induce weight gain monitor physical activity hunger/appetite change course treatment .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>We include child , age 7 12 year old , male female diagnosis bipolar spectrum disorder . Specific diagnosis include follow : Bipolar I disorder , Bipolar II disorder , Bipolar Disorder Not Otherwise Specified , Mood Disorder Not otherwise specify . The inclusion spectrum bipolar diagnosis child moderate severe impairment mood symptom often still meet criterion Bipolar I disorder since young child tend chronic ( nonepisodic ) course symptom diagnostic criterion Bipolar I disorder difficult apply adult young child ( e.g . symptom grandiosity euphoria ) . No prior treatment antipsychotic medication &gt; 30 day . This criterion add weight loss assign treatment may due discontinue prior antipsychotic medication rather due current treatment . Recommendation current psychiatric treatment provider treatment antipsychotic medication . This inclusion criterion provide added layer safety youth refer study already deem independent provider need antipsychotic medication , expose child antipsychotic treatment would treat type medication regardless whether care provide research clinical program . Medications : We exclude child current treatment oral steroid , lithium , depakote since medication confound effect weight . We allow child stimulant medication participate , ADHD comorbidity high prepubertal bipolar disorder ( unlike adolescent adult onset bipolar disorder ) . We include ADHD child thus increase generalizability study , would inappropriate withhold stimulant treatment child six month period . Recruitment stratify make sure equal number patient stimulant group . Somatic Conditions : We exclude child diabetes ( type I type II ) , physical disability would interfere physical activity ( specifically exclude child whose guardian report child medically excused physical education school program physical disability ) since insulin sensitivity activity level outcome measure assess protocol . We exclude youth mental retardation , parent report . Cognitive screen do Wechsler Abbreviated Scale Intelligence ( WASI ) . Youth IQ le 70 exclude may difficulty self report measure . We exclude child history treatment antipsychotic medication &gt; 30 day , explain .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>bipolar</keyword>
	<keyword>child</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>side effect</keyword>
</DOC>